Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19fc1ece6f10306bcb51a915894d174f |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
filingDate |
1995-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5607cacc204d4e1475bd17b28c92ca8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58586619efa86eb55dc2d96c6fec3d28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d309ee0ef2dcb1c247ae007b42598c10 |
publicationDate |
1996-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H08208489-A |
titleOfInvention |
Renal failure treatment |
abstract |
(57) [Summary] [Purpose] To provide a therapeutic agent for secondary hyperparathyroidism, which is caused by a decrease in renal function such as chronic renal failure. [PROBLEMS] To provide a therapeutic agent for renal failure containing chitosan or iron-chitosan complex as an active ingredient, and a therapeutic agent for secondary hyperparathyroidism containing chitosan or iron-chitosan complex as an active ingredient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013505284-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006206505-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1027053-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2425722-A3 |
priorityDate |
1995-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |